Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amoxicillin | 1 | 2023 | 169 | 0.840 |
Why?
|
| Croup | 1 | 2022 | 25 | 0.840 |
Why?
|
| Otitis Media | 1 | 2023 | 284 | 0.760 |
Why?
|
| Meningioma | 5 | 2020 | 1218 | 0.700 |
Why?
|
| Meningeal Neoplasms | 5 | 2020 | 1249 | 0.680 |
Why?
|
| Propranolol | 1 | 2021 | 501 | 0.680 |
Why?
|
| Social Justice | 2 | 2022 | 465 | 0.660 |
Why?
|
| Lymphopenia | 1 | 2021 | 283 | 0.650 |
Why?
|
| Tachycardia | 1 | 2021 | 619 | 0.650 |
Why?
|
| Housing | 1 | 2023 | 673 | 0.630 |
Why?
|
| Bibliometrics | 1 | 2022 | 348 | 0.630 |
Why?
|
| Value of Life | 1 | 2018 | 97 | 0.620 |
Why?
|
| Cultural Competency | 1 | 2020 | 294 | 0.570 |
Why?
|
| Biodiversity | 1 | 2019 | 342 | 0.550 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 1235 | 0.510 |
Why?
|
| Publishing | 1 | 2022 | 840 | 0.490 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 980 | 0.490 |
Why?
|
| Baseball | 1 | 2015 | 92 | 0.480 |
Why?
|
| Shock, Septic | 1 | 2021 | 777 | 0.480 |
Why?
|
| Head Protective Devices | 1 | 2015 | 114 | 0.470 |
Why?
|
| Ischemia | 1 | 2021 | 1924 | 0.410 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2021 | 1370 | 0.390 |
Why?
|
| Patient Selection | 1 | 2023 | 4232 | 0.370 |
Why?
|
| Intensive Care Units | 1 | 2024 | 3717 | 0.370 |
Why?
|
| Telemedicine | 3 | 2023 | 2990 | 0.360 |
Why?
|
| Sarcoma | 1 | 2021 | 1903 | 0.340 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 2546 | 0.320 |
Why?
|
| Education, Medical | 1 | 2020 | 1724 | 0.310 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 7970 | 0.290 |
Why?
|
| Curriculum | 1 | 2020 | 3633 | 0.280 |
Why?
|
| Students, Medical | 1 | 2018 | 1887 | 0.250 |
Why?
|
| Physicians | 1 | 2023 | 4625 | 0.250 |
Why?
|
| Clinical Competence | 1 | 2020 | 4729 | 0.240 |
Why?
|
| Brain Concussion | 1 | 2015 | 1317 | 0.240 |
Why?
|
| Otolaryngology | 2 | 2020 | 653 | 0.220 |
Why?
|
| Tablets | 1 | 2023 | 145 | 0.210 |
Why?
|
| Milk Hypersensitivity | 1 | 2022 | 76 | 0.200 |
Why?
|
| Calibration | 1 | 2024 | 820 | 0.200 |
Why?
|
| Acidosis, Lactic | 1 | 2022 | 144 | 0.190 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 370 | 0.190 |
Why?
|
| Hypertension | 1 | 2021 | 8614 | 0.190 |
Why?
|
| Clindamycin | 1 | 2021 | 139 | 0.190 |
Why?
|
| Prescriptions | 1 | 2023 | 387 | 0.180 |
Why?
|
| Therapeutic Irrigation | 1 | 2021 | 302 | 0.180 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2019 | 43 | 0.170 |
Why?
|
| Vasopressins | 1 | 2021 | 369 | 0.170 |
Why?
|
| Child | 8 | 2023 | 78594 | 0.170 |
Why?
|
| Humans | 36 | 2024 | 752741 | 0.170 |
Why?
|
| Implantable Neurostimulators | 1 | 2019 | 76 | 0.160 |
Why?
|
| Ecology | 1 | 2019 | 105 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 788 | 0.160 |
Why?
|
| Norepinephrine | 1 | 2021 | 912 | 0.160 |
Why?
|
| Debridement | 1 | 2021 | 494 | 0.160 |
Why?
|
| Globus Pallidus | 1 | 2019 | 252 | 0.160 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2017 | 15 | 0.150 |
Why?
|
| Epinephrine | 1 | 2021 | 794 | 0.150 |
Why?
|
| India | 1 | 2024 | 2239 | 0.150 |
Why?
|
| Nasopharynx | 1 | 2020 | 394 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 832 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2023 | 1687 | 0.150 |
Why?
|
| Biotechnology | 1 | 2019 | 280 | 0.150 |
Why?
|
| Health Literacy | 1 | 2022 | 425 | 0.150 |
Why?
|
| Essential Tremor | 1 | 2019 | 151 | 0.150 |
Why?
|
| Africa | 1 | 2019 | 696 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2021 | 590 | 0.140 |
Why?
|
| Subthalamic Nucleus | 1 | 2019 | 193 | 0.140 |
Why?
|
| Hematology | 1 | 2019 | 224 | 0.140 |
Why?
|
| Endoscopes | 1 | 2017 | 175 | 0.140 |
Why?
|
| Encephalocele | 1 | 2017 | 140 | 0.140 |
Why?
|
| ROC Curve | 1 | 2024 | 3558 | 0.140 |
Why?
|
| History, 19th Century | 2 | 2015 | 722 | 0.130 |
Why?
|
| Leg | 1 | 2021 | 1123 | 0.130 |
Why?
|
| American Civil War | 1 | 2015 | 8 | 0.130 |
Why?
|
| Labyrinth Diseases | 1 | 2017 | 150 | 0.130 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 1211 | 0.130 |
Why?
|
| Semicircular Canals | 1 | 2017 | 198 | 0.130 |
Why?
|
| Psychosurgery | 1 | 2015 | 87 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2020 | 702 | 0.130 |
Why?
|
| Rhabdoid Tumor | 1 | 2017 | 216 | 0.120 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 643 | 0.120 |
Why?
|
| Famous Persons | 1 | 2015 | 109 | 0.120 |
Why?
|
| Liability, Legal | 1 | 2015 | 215 | 0.120 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 455 | 0.120 |
Why?
|
| Diskectomy | 1 | 2015 | 202 | 0.120 |
Why?
|
| Schools | 1 | 2022 | 1443 | 0.110 |
Why?
|
| History, 20th Century | 3 | 2015 | 2766 | 0.110 |
Why?
|
| Craniotomy | 1 | 2017 | 737 | 0.110 |
Why?
|
| Acute Disease | 1 | 2023 | 7221 | 0.110 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 6542 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5144 | 0.110 |
Why?
|
| Infant | 3 | 2023 | 35447 | 0.110 |
Why?
|
| Spinal Neoplasms | 1 | 2019 | 706 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2024 | 78758 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2023 | 7852 | 0.100 |
Why?
|
| Social Class | 1 | 2020 | 2005 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 25454 | 0.100 |
Why?
|
| Deep Brain Stimulation | 1 | 2019 | 785 | 0.100 |
Why?
|
| Graft vs Host Disease | 1 | 2023 | 2957 | 0.100 |
Why?
|
| Nutritional Status | 1 | 2019 | 1610 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1517 | 0.090 |
Why?
|
| Communicable Diseases | 1 | 2019 | 892 | 0.090 |
Why?
|
| Malpractice | 1 | 2015 | 574 | 0.090 |
Why?
|
| Poverty | 1 | 2022 | 2682 | 0.090 |
Why?
|
| Temporal Lobe | 1 | 2017 | 1683 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2018 | 2526 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2022 | 9863 | 0.090 |
Why?
|
| Survival Rate | 2 | 2021 | 12802 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2020 | 2738 | 0.080 |
Why?
|
| Middle Aged | 10 | 2024 | 216054 | 0.080 |
Why?
|
| Pediatrics | 1 | 2023 | 3517 | 0.080 |
Why?
|
| Life Style | 1 | 2019 | 3861 | 0.070 |
Why?
|
| Logistic Models | 1 | 2022 | 13441 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3531 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 2846 | 0.070 |
Why?
|
| Female | 13 | 2024 | 385090 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2927 | 0.070 |
Why?
|
| Probiotics | 2 | 2019 | 354 | 0.070 |
Why?
|
| Health Care Reform | 1 | 2015 | 1272 | 0.070 |
Why?
|
| Adolescent | 3 | 2023 | 86713 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2020 | 2812 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 13042 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2822 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 5222 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7269 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14219 | 0.060 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2023 | 90 | 0.060 |
Why?
|
| Aged | 5 | 2024 | 165629 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2015 | 2033 | 0.060 |
Why?
|
| Genomics | 1 | 2019 | 5743 | 0.060 |
Why?
|
| Male | 8 | 2024 | 354311 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 2436 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 167 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3136 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3246 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5380 | 0.050 |
Why?
|
| Diet | 1 | 2019 | 7969 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 40939 | 0.050 |
Why?
|
| Adult | 4 | 2024 | 216658 | 0.050 |
Why?
|
| United States | 4 | 2023 | 70772 | 0.050 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2022 | 350 | 0.040 |
Why?
|
| Milk | 1 | 2022 | 450 | 0.040 |
Why?
|
| Receptors, Prostaglandin | 1 | 2018 | 57 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12165 | 0.040 |
Why?
|
| Metagenomics | 1 | 2022 | 438 | 0.040 |
Why?
|
| Steroids | 1 | 2023 | 940 | 0.040 |
Why?
|
| Cranial Fossa, Middle | 1 | 2017 | 28 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 11909 | 0.040 |
Why?
|
| Stereotaxic Techniques | 1 | 2019 | 538 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2021 | 64017 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 359 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 563 | 0.040 |
Why?
|
| Pandemics | 3 | 2022 | 8607 | 0.040 |
Why?
|
| South Africa | 1 | 2022 | 1740 | 0.040 |
Why?
|
| Chondrosarcoma | 1 | 2019 | 308 | 0.030 |
Why?
|
| Efficiency | 1 | 2019 | 468 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2018 | 472 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 12868 | 0.030 |
Why?
|
| Office Visits | 1 | 2020 | 600 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2015 | 6699 | 0.030 |
Why?
|
| Head Injuries, Penetrating | 1 | 2015 | 28 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 491 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 8947 | 0.030 |
Why?
|
| Physical Examination | 1 | 2020 | 1237 | 0.030 |
Why?
|
| SEER Program | 1 | 2019 | 1510 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2019 | 881 | 0.030 |
Why?
|
| Temporal Bone | 1 | 2017 | 675 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1779 | 0.030 |
Why?
|
| Homicide | 1 | 2015 | 292 | 0.030 |
Why?
|
| Learning | 1 | 2022 | 1727 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2018 | 1436 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 884 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 5469 | 0.020 |
Why?
|
| Rural Population | 1 | 2022 | 2245 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2016 | 1255 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2019 | 4794 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 1483 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 6233 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3354 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3572 | 0.020 |
Why?
|
| Leptin | 1 | 2018 | 1621 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2018 | 2967 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 2297 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 863 | 0.020 |
Why?
|
| Wounds, Gunshot | 1 | 2015 | 577 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1814 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2423 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2473 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2901 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1856 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8660 | 0.020 |
Why?
|
| Mutation | 3 | 2017 | 29981 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2492 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4179 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 2028 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10469 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10252 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5851 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10508 | 0.010 |
Why?
|
| Critical Care | 1 | 2015 | 2696 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9657 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18460 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21904 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13364 | 0.010 |
Why?
|
| Animals | 2 | 2022 | 169600 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29264 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 53863 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39223 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 81766 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58361 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 57267 | 0.010 |
Why?
|
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(61)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_